These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 33968042)

  • 21. The extent of desmoglein 3 depletion in pemphigus vulgaris is dependent on Ca(2+)-induced differentiation: a role in suprabasal epidermal skin splitting?
    Spindler V; Endlich A; Hartlieb E; Vielmuth F; Schmidt E; Waschke J
    Am J Pathol; 2011 Oct; 179(4):1905-16. PubMed ID: 21864491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigus.
    Walter E; Vielmuth F; Rotkopf L; Sárdy M; Horváth ON; Goebeler M; Schmidt E; Eming R; Hertl M; Spindler V; Waschke J
    Sci Rep; 2017 Jun; 7(1):3579. PubMed ID: 28620161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MAPKAP kinase 2 (MK2)-dependent and -independent models of blister formation in pemphigus vulgaris.
    Mao X; Li H; Sano Y; Gaestel M; Mo Park J; Payne AS
    J Invest Dermatol; 2014 Jan; 134(1):68-76. PubMed ID: 23657501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies.
    Calkins CC; Setzer SV; Jennings JM; Summers S; Tsunoda K; Amagai M; Kowalczyk AP
    J Biol Chem; 2006 Mar; 281(11):7623-34. PubMed ID: 16377623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris].
    Zhong S; Qiu YF; Han BB; Zhao JY; Zhu XJ; Chen XX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):414-5. PubMed ID: 21681274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clues to diagnosis for unusual mucosal pemphigus demonstrating undetectable anti-desmoglein 3 serum antibodies by routine tests.
    Kamiya K; Aoyama Y; Yamaguchi M; Ukida A; Mizuno-Ikeda K; Fujii K; Hamada T; Tokura Y; Iwatsuki K
    J Dermatol; 2015 Jun; 42(6):572-9. PubMed ID: 25832452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-junctional human desmoglein 3 acts as an upstream regulator of Src in E-cadherin adhesion, a pathway possibly involved in the pathogenesis of pemphigus vulgaris.
    Tsang SM; Brown L; Lin K; Liu L; Piper K; O'Toole EA; Grose R; Hart IR; Garrod DR; Fortune F; Wan H
    J Pathol; 2012 May; 227(1):81-93. PubMed ID: 22294297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low pathogenicity of anti-desmoglein 3 immunoglobulin G autoantibodies contributes to the atypical clinical phenotypes in pemphigus.
    Saleh MA; Hashimoto R; Kase Y; Amagai M; Yamagami J
    J Dermatol; 2015 Jul; 42(7):685-9. PubMed ID: 25914046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pathogenic autoantibody, pemphigus vulgaris-IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes.
    Aoyama Y; Owada MK; Kitajima Y
    Eur J Immunol; 1999 Jul; 29(7):2233-40. PubMed ID: 10427986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Actin reorganization contributes to loss of cell adhesion in pemphigus vulgaris.
    Gliem M; Heupel WM; Spindler V; Harms GS; Waschke J
    Am J Physiol Cell Physiol; 2010 Sep; 299(3):C606-13. PubMed ID: 20554911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A higher correlation of the antibody activities against the calcium-dependent epitopes of desmoglein 3 quantified by ethylenediaminetetraacetic acid-treated enzyme-linked immunosorbent assay with clinical disease activities of pemphigus vulgaris.
    Kamiya K; Aoyama Y; Shirafuji Y; Hamada T; Morizane S; Fujii K; Iwatsuki K
    J Dermatol Sci; 2013 Jun; 70(3):190-5. PubMed ID: 23602628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Standardized Production of Anti-Desmoglein 3 Antibody AK23 for Translational Pemphigus Vulgaris Research.
    Mueller EJ; Rahimi S; Sauta P; Shojaeian T; Durrer L; Quinche S; Francois M; Locher E; Edler M; Illi M; Gentinetta T; Lau K; Pojer F; Borradori L; Hariton WVJ
    Curr Protoc; 2024 Aug; 4(8):e1118. PubMed ID: 39169810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-Desmoglein Antibodies in Patients With Pemphigus Vulgaris.
    Amber KT; Valdebran M; Grando SA
    Front Immunol; 2018; 9():1190. PubMed ID: 29915578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tacrolimus reverses pemphigus vulgaris serum-induced depletion of desmoglein in HaCaT cells via inhibition of heat shock protein 27 phosphorylation.
    Xie Z; Dai X; Li Q; Lin S; Ye X
    BMC Immunol; 2023 Nov; 24(1):43. PubMed ID: 37940861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum and salivary IgG and IgA antibodies to desmoglein 3 in mucosal pemphigus vulgaris.
    Ali S; Kelly C; Challacombe SJ; Donaldson AN; Bhogal BS; Setterfield JF
    Br J Dermatol; 2016 Jul; 175(1):113-21. PubMed ID: 26799252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Signaling dependent and independent mechanisms in pemphigus vulgaris blister formation.
    Saito M; Stahley SN; Caughman CY; Mao X; Tucker DK; Payne AS; Amagai M; Kowalczyk AP
    PLoS One; 2012; 7(12):e50696. PubMed ID: 23226536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of the desmosomal protein perp enhances the phenotypic effects of pemphigus vulgaris autoantibodies.
    Nguyen B; Dusek RL; Beaudry VG; Marinkovich MP; Attardi LD
    J Invest Dermatol; 2009 Jul; 129(7):1710-8. PubMed ID: 19158843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controversial role of antibodies against linear epitopes of desmoglein 3 in pemphigus vulgaris, as revealed by semiquantitative living cell immunofluorescence microscopy and in-cell ELISA.
    Lanza A; Perillo L; Landi C; Femiano F; Gombos F; Cirillo N
    Int J Immunopathol Pharmacol; 2010; 23(4):1047-55. PubMed ID: 21244754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical pemphigus with immunoglobulin G autoantibodies against desmoglein 3 and desmocollin 3.
    Kamiya K; Aoyama Y; Wakashima C; Kudo T; Nakajima K; Sano S; Ishii N; Teye K; Hashimoto T; Iwatsuki K; Tokura Y
    J Dermatol; 2016 Apr; 43(4):429-31. PubMed ID: 26331291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
    Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.